NZ500887A - Nucleic acid encoding lipid transfer protein which exhibits SAR (systemic acquired resistance) by specific process - Google Patents
Nucleic acid encoding lipid transfer protein which exhibits SAR (systemic acquired resistance) by specific processInfo
- Publication number
- NZ500887A NZ500887A NZ500887A NZ50088798A NZ500887A NZ 500887 A NZ500887 A NZ 500887A NZ 500887 A NZ500887 A NZ 500887A NZ 50088798 A NZ50088798 A NZ 50088798A NZ 500887 A NZ500887 A NZ 500887A
- Authority
- NZ
- New Zealand
- Prior art keywords
- sar
- plant
- nucleic acid
- salicylic acid
- plants
- Prior art date
Links
- 108010053156 lipid transfer protein Proteins 0.000 title claims abstract description 40
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 39
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 39
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 39
- 230000021918 systemic acquired resistance Effects 0.000 title claims description 162
- 238000000034 method Methods 0.000 title claims description 36
- 230000008569 process Effects 0.000 title claims description 7
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims abstract description 161
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 113
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims abstract description 80
- 229960004889 salicylic acid Drugs 0.000 claims abstract description 80
- 230000019491 signal transduction Effects 0.000 claims abstract description 46
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 45
- 239000002054 inoculum Substances 0.000 claims abstract description 25
- 238000011144 upstream manufacturing Methods 0.000 claims abstract description 22
- 201000010099 disease Diseases 0.000 claims abstract description 21
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 21
- 230000009471 action Effects 0.000 claims abstract description 19
- 208000024891 symptom Diseases 0.000 claims abstract description 18
- 230000035772 mutation Effects 0.000 claims abstract description 17
- 239000002299 complementary DNA Substances 0.000 claims abstract description 16
- 238000012360 testing method Methods 0.000 claims abstract description 13
- 239000000126 substance Substances 0.000 claims abstract description 7
- 230000002463 transducing effect Effects 0.000 claims abstract 9
- 239000013598 vector Substances 0.000 claims description 18
- 108020004414 DNA Proteins 0.000 claims description 16
- 239000002773 nucleotide Substances 0.000 claims description 11
- 125000003729 nucleotide group Chemical group 0.000 claims description 11
- 230000001131 transforming effect Effects 0.000 claims description 5
- 230000001747 exhibiting effect Effects 0.000 claims description 4
- 238000005507 spraying Methods 0.000 claims description 4
- 238000012546 transfer Methods 0.000 claims description 4
- 108020004511 Recombinant DNA Proteins 0.000 claims description 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 6
- 230000001010 compromised effect Effects 0.000 claims 3
- 102000053602 DNA Human genes 0.000 claims 2
- 239000013611 chromosomal DNA Substances 0.000 claims 2
- 239000003471 mutagenic agent Substances 0.000 claims 2
- 231100000707 mutagenic chemical Toxicity 0.000 claims 2
- 230000003505 mutagenic effect Effects 0.000 claims 2
- 241000196324 Embryophyta Species 0.000 description 113
- 241001070944 Mimosa Species 0.000 description 25
- 241000219194 Arabidopsis Species 0.000 description 24
- 238000011081 inoculation Methods 0.000 description 24
- 235000011468 Albizia julibrissin Nutrition 0.000 description 22
- 229930027917 kanamycin Natural products 0.000 description 22
- 229960000318 kanamycin Drugs 0.000 description 22
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 22
- 229930182823 kanamycin A Natural products 0.000 description 22
- 230000014509 gene expression Effects 0.000 description 19
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 16
- 244000061176 Nicotiana tabacum Species 0.000 description 14
- SQSYNRCXIZHKAI-UHFFFAOYSA-N 2,6-dichloroisonicotinic acid Chemical compound OC(=O)C1=CC(Cl)=NC(Cl)=C1 SQSYNRCXIZHKAI-UHFFFAOYSA-N 0.000 description 13
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 13
- 238000011282 treatment Methods 0.000 description 13
- 230000002950 deficient Effects 0.000 description 12
- 230000009885 systemic effect Effects 0.000 description 12
- 229910001629 magnesium chloride Inorganic materials 0.000 description 11
- 230000001580 bacterial effect Effects 0.000 description 10
- 230000006698 induction Effects 0.000 description 10
- 238000003780 insertion Methods 0.000 description 9
- 230000037431 insertion Effects 0.000 description 9
- 244000052769 pathogen Species 0.000 description 9
- 238000012512 characterization method Methods 0.000 description 8
- 238000002955 isolation Methods 0.000 description 8
- 241000219823 Medicago Species 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 240000008067 Cucumis sativus Species 0.000 description 6
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 230000003053 immunization Effects 0.000 description 6
- 239000000411 inducer Substances 0.000 description 6
- 230000037361 pathway Effects 0.000 description 6
- 230000004044 response Effects 0.000 description 6
- 230000009261 transgenic effect Effects 0.000 description 6
- 238000009825 accumulation Methods 0.000 description 5
- 239000003242 anti bacterial agent Substances 0.000 description 5
- 229940088710 antibiotic agent Drugs 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 210000002257 embryonic structure Anatomy 0.000 description 5
- 238000003752 polymerase chain reaction Methods 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 238000012163 sequencing technique Methods 0.000 description 5
- 108700023096 Arabidopsis dir1-1 Proteins 0.000 description 4
- 208000035240 Disease Resistance Diseases 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 4
- 150000001413 amino acids Chemical group 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000010369 molecular cloning Methods 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 101150057323 sar gene Proteins 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 240000005979 Hordeum vulgare Species 0.000 description 3
- 235000007340 Hordeum vulgare Nutrition 0.000 description 3
- 235000016462 Mimosa pudica Nutrition 0.000 description 3
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 3
- 241000723873 Tobacco mosaic virus Species 0.000 description 3
- 230000004665 defense response Effects 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000002649 immunization Methods 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 235000021374 legumes Nutrition 0.000 description 3
- 238000013507 mapping Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 241000589158 Agrobacterium Species 0.000 description 2
- YAXNATKKPOWVCP-ZLUOBGJFSA-N Ala-Asn-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O YAXNATKKPOWVCP-ZLUOBGJFSA-N 0.000 description 2
- XUCHENWTTBFODJ-FXQIFTODSA-N Ala-Met-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(O)=O XUCHENWTTBFODJ-FXQIFTODSA-N 0.000 description 2
- DCVYRWFAMZFSDA-ZLUOBGJFSA-N Ala-Ser-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DCVYRWFAMZFSDA-ZLUOBGJFSA-N 0.000 description 2
- PDECQIHABNQRHN-GUBZILKMSA-N Asp-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(O)=O PDECQIHABNQRHN-GUBZILKMSA-N 0.000 description 2
- AITKTFCQOBRJTG-CIUDSAMLSA-N Asp-Leu-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(=O)O)N AITKTFCQOBRJTG-CIUDSAMLSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- LBOLGUYQEPZSKM-YUMQZZPRSA-N Cys-Gly-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CS)N LBOLGUYQEPZSKM-YUMQZZPRSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- KZTLOHBDLMIFSH-XVYDVKMFSA-N His-Ala-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(O)=O KZTLOHBDLMIFSH-XVYDVKMFSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- IASQBRJGRVXNJI-YUMQZZPRSA-N Leu-Cys-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)NCC(O)=O IASQBRJGRVXNJI-YUMQZZPRSA-N 0.000 description 2
- VGPCJSXPPOQPBK-YUMQZZPRSA-N Leu-Gly-Ser Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O VGPCJSXPPOQPBK-YUMQZZPRSA-N 0.000 description 2
- YRRCOJOXAJNSAX-IHRRRGAJSA-N Leu-Pro-Lys Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O)N YRRCOJOXAJNSAX-IHRRRGAJSA-N 0.000 description 2
- 241000209510 Liliopsida Species 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- XOQMURBBIXRRCR-SRVKXCTJSA-N Lys-Lys-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN XOQMURBBIXRRCR-SRVKXCTJSA-N 0.000 description 2
- VTKPSXWRUGCOAC-GUBZILKMSA-N Met-Ala-Met Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCSC VTKPSXWRUGCOAC-GUBZILKMSA-N 0.000 description 2
- WXHHTBVYQOSYSL-FXQIFTODSA-N Met-Ala-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O WXHHTBVYQOSYSL-FXQIFTODSA-N 0.000 description 2
- FMYLZGQFKPHXHI-GUBZILKMSA-N Met-Met-Ala Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(O)=O FMYLZGQFKPHXHI-GUBZILKMSA-N 0.000 description 2
- 241001092142 Molina Species 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- MDHZEOMXGNBSIL-DLOVCJGASA-N Phe-Ala-Cys Chemical compound C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N MDHZEOMXGNBSIL-DLOVCJGASA-N 0.000 description 2
- WFLWKEUBTSOFMP-FXQIFTODSA-N Pro-Cys-Cys Chemical compound OC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1 WFLWKEUBTSOFMP-FXQIFTODSA-N 0.000 description 2
- MDAWMJUZHBQTBO-XGEHTFHBSA-N Pro-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@@H]1CCCN1)O MDAWMJUZHBQTBO-XGEHTFHBSA-N 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- 241000589615 Pseudomonas syringae Species 0.000 description 2
- 238000002123 RNA extraction Methods 0.000 description 2
- BVLGVLWFIZFEAH-BPUTZDHNSA-N Ser-Pro-Trp Chemical compound [H]N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O BVLGVLWFIZFEAH-BPUTZDHNSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- BSNZTJXVDOINSR-JXUBOQSCSA-N Thr-Ala-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O BSNZTJXVDOINSR-JXUBOQSCSA-N 0.000 description 2
- 108091036066 Three prime untranslated region Proteins 0.000 description 2
- GITNQBVCEQBDQC-KKUMJFAQSA-N Tyr-Lys-Asn Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O GITNQBVCEQBDQC-KKUMJFAQSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 108010087924 alanylproline Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 108010016616 cysteinylglycine Proteins 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 108010037389 glutamyl-cysteinyl-lysine Proteins 0.000 description 2
- 108010074027 glycyl-seryl-phenylalanine Proteins 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 108010016686 methionyl-alanyl-serine Proteins 0.000 description 2
- 208000013435 necrotic lesion Diseases 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
- 230000000644 propagated effect Effects 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000030118 somatic embryogenesis Effects 0.000 description 2
- 229940027257 timentin Drugs 0.000 description 2
- 108010080629 tryptophan-leucine Proteins 0.000 description 2
- GAISRYMZAXLPHD-UHFFFAOYSA-N 2-hydroxybenzoic acid;methanol Chemical compound OC.OC(=O)C1=CC=CC=C1O GAISRYMZAXLPHD-UHFFFAOYSA-N 0.000 description 1
- ORILYTVJVMAKLC-UHFFFAOYSA-N Adamantane Natural products C1C(C2)CC3CC1CC2C3 ORILYTVJVMAKLC-UHFFFAOYSA-N 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- MECFLTFREHAZLH-ACZMJKKPSA-N Asn-Glu-Cys Chemical compound C(CC(=O)O)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(=O)N)N MECFLTFREHAZLH-ACZMJKKPSA-N 0.000 description 1
- IDUUACUJKUXKKD-VEVYYDQMSA-N Asn-Pro-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O IDUUACUJKUXKKD-VEVYYDQMSA-N 0.000 description 1
- AHWRSSLYSGLBGD-CIUDSAMLSA-N Asp-Pro-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O AHWRSSLYSGLBGD-CIUDSAMLSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 235000011303 Brassica alboglabra Nutrition 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000011302 Brassica oleracea Nutrition 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 101100285688 Caenorhabditis elegans hrg-7 gene Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000701489 Cauliflower mosaic virus Species 0.000 description 1
- 241000222199 Colletotrichum Species 0.000 description 1
- 241000222235 Colletotrichum orbiculare Species 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 101710114192 Elicitin Proteins 0.000 description 1
- 241000701533 Escherichia virus T4 Species 0.000 description 1
- 101000631953 Foeniculum vulgare Non-specific lipid-transfer protein 1 Proteins 0.000 description 1
- ISXJHXGYMJKXOI-GUBZILKMSA-N Glu-Cys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCC(O)=O ISXJHXGYMJKXOI-GUBZILKMSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- OMOZPGCHVWOXHN-BQBZGAKWSA-N Gly-Met-Ser Chemical compound CSCC[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)CN OMOZPGCHVWOXHN-BQBZGAKWSA-N 0.000 description 1
- DNVDEMWIYLVIQU-RCOVLWMOSA-N Gly-Val-Asp Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O DNVDEMWIYLVIQU-RCOVLWMOSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- BOJYMMBYBNOOGG-DCAQKATOSA-N Lys-Pro-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O BOJYMMBYBNOOGG-DCAQKATOSA-N 0.000 description 1
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 101710196810 Non-specific lipid-transfer protein 2 Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 101710096342 Pathogenesis-related protein Proteins 0.000 description 1
- 101150005926 Pc gene Proteins 0.000 description 1
- 101000631973 Peganum harmala Non-specific lipid-transfer protein PHP Proteins 0.000 description 1
- 235000002233 Penicillium roqueforti Nutrition 0.000 description 1
- 241001223281 Peronospora Species 0.000 description 1
- HNFUGJUZJRYUHN-JSGCOSHPSA-N Phe-Gly-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 HNFUGJUZJRYUHN-JSGCOSHPSA-N 0.000 description 1
- 102000006486 Phosphoinositide Phospholipase C Human genes 0.000 description 1
- 108010044302 Phosphoinositide phospholipase C Proteins 0.000 description 1
- 108010053210 Phycocyanin Proteins 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 108020005089 Plant RNA Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- OOLOTUZJUBOMAX-GUBZILKMSA-N Pro-Ala-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O OOLOTUZJUBOMAX-GUBZILKMSA-N 0.000 description 1
- NXEYSLRNNPWCRN-SRVKXCTJSA-N Pro-Glu-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O NXEYSLRNNPWCRN-SRVKXCTJSA-N 0.000 description 1
- RMJZWERKFFNNNS-XGEHTFHBSA-N Pro-Thr-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O RMJZWERKFFNNNS-XGEHTFHBSA-N 0.000 description 1
- 102000006010 Protein Disulfide-Isomerase Human genes 0.000 description 1
- 101100492348 Pseudomonas syringae pv. tomato avrRpt2 gene Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- GVMUJUPXFQFBBZ-GUBZILKMSA-N Ser-Lys-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O GVMUJUPXFQFBBZ-GUBZILKMSA-N 0.000 description 1
- AZWNCEBQZXELEZ-FXQIFTODSA-N Ser-Pro-Ser Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O AZWNCEBQZXELEZ-FXQIFTODSA-N 0.000 description 1
- PMTWIUBUQRGCSB-FXQIFTODSA-N Ser-Val-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O PMTWIUBUQRGCSB-FXQIFTODSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 102100021588 Sterol carrier protein 2 Human genes 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- IEZVHOULSUULHD-XGEHTFHBSA-N Thr-Ser-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O IEZVHOULSUULHD-XGEHTFHBSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- OVLIFGQSBSNGHY-KKHAAJSZSA-N Val-Asp-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)N)O OVLIFGQSBSNGHY-KKHAAJSZSA-N 0.000 description 1
- QTPQHINADBYBNA-DCAQKATOSA-N Val-Ser-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN QTPQHINADBYBNA-DCAQKATOSA-N 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 1
- 108010093581 aspartyl-proline Proteins 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- 244000000005 bacterial plant pathogen Species 0.000 description 1
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical class C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 208000022602 disease susceptibility Diseases 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 230000000408 embryogenic effect Effects 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 244000000004 fungal plant pathogen Species 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 238000010448 genetic screening Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 101150054900 gus gene Proteins 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000020868 induced systemic resistance Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002743 insertional mutagenesis Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 108010009298 lysylglutamic acid Proteins 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 108010058731 nopaline synthase Proteins 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000005305 organ development Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 230000003032 phytopathogenic effect Effects 0.000 description 1
- 230000008659 phytopathology Effects 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 108020003519 protein disulfide isomerase Proteins 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 108010026333 seryl-proline Proteins 0.000 description 1
- 230000009131 signaling function Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 108010058363 sterol carrier proteins Proteins 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000012250 transgenic expression Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 239000003656 tris buffered saline Substances 0.000 description 1
- 241000709655 unidentified tobacco necrosis virus Species 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8281—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for bacterial resistance
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
A nucleic acid molecule which encodes a lipid transfer protein wherein the encoded lipid transfer protein exhibits a SAR signal transducing property. The nucleic acid molecule is obtained by the steps of: a) growing wild type and T-DNA transformed plants and observing for disease symptoms; b) isolating SAR mutants showing disease symptoms; c) performing SAR competence tests to validate the SAR mutation in the SAR mutants, wherein the SAR is comprised in a SAR mutant plant upon first being treated on one leaf of the plant with an avirulent inoculum and later being treated on other leaves if the plant with virulent inoculum as compared to a wild type plant which exhibits SAR upon first being treated on one leaf with an avirulent inoculum and later being treated on other leaves with a virulent inoculum; d) testing the SAR mutants to determine the position of the mutant gene in relation to the point of salicylic acid action in the signal transduction pathway, wherein the SAR mutants which are first sprayed with substance that mimics salicylic acid and acts at about the same point as salicylic acid in the SAR signal transduction pathway, challenged with a virulent inoculum, and then remain symptomless exhibit a SAR mutant gene upstream of the point of salicylic acid action in the signal transduction pathway; e) isolating DNA from those plants which are homozygous for SAR mutant gene, and where the gene is found to encode a protein which acts upstream from the site of salicylic acid action alone the signal transduction pathway; and f) probing the DNA to isolate cDNA.
Description
1 PCT/U S98/09863 GENE ENCODING FOR SYSTEMIC ACQUIRED RESISTANCE IN ARABIDOPSIS TECHNICAL FIELD This invention relates to a gene specific to the signal transduction pathway for systemic acquired resistance in plants CROSS REFERENCE TO RELATED APPLICATION This application claims the benefit of prior filed copending U S Provisional Application No 60/046,475 filed May 14, 1997 Printed from Mimosa WO 98/51801 PCT/US98/09863 2 BACKGROUND OF THE INVENTION The signal transduction pathway in plants that leads to Systemic Acquired Resistance (SAR) involves a number of stages The first stage is the induction or immunization stage, where initial infection of a leaf by a pathogen to which the plant is resistant results in a hypersensitive response (HR) leading to the formation of necrotic lesions There are, however, some examples in which SAR occurs without necrosis Cameron, et al, "Biologically induced systemic acquired resistance in Arabidopsis thahana," Plant J 5 715-725 (1994), Keller, et al, "Physiological and molecular characteristics of elicitin-induced systemic acquired resistance in tobacco," Plant Physiol 110 365-376 (1996) The expression in the inoculated leaf of a set of pathogenesis-related (PR) protein genes, commonly referred to as SAR genes, occurs during this induction stage in tobacco and cucumber (Kuc', J , Bioscience 32 854-856 (1982), Ward, et al, "Coordinate gene activity in response to agents that induce systemic acquired resistance," Plant Cell 3 49-59 (1991))and m Arabidopsis (Uknes, et al, "Acquired resistance in Arabidopsis," Plant Cell 4 645-656 (1992)), Uknes, et al, "Biological induction of systemic acquired resistance in Arabidopsis," Mol Plant-Microbe Interact 6 692-698 (1993)) Accumulation of salicylic acid (10- to 50-fold increase) also occurs during this stage Yalpani, et al, "Salicylic acid is a systemic signal and an inducer of pathogenesis-related proteins in virus-infected tobacco," Plant Cell 3 809-818 (1991), Malamy, et al, "Salicylic acid A likely endogenous signal in the resistance response of tobacco to viral infection," Science 250 1002-1004 (1990), Metraux, et al, "Increase in salicylic acid at the onset of systemic acquired resistance in cucumber," Science 250 1004-1006 (1990), Uknes, et al, Plant Cell A 645-656 (1992), Vernooij, et al, "Salicylic acid is not the translocated signal responsible for inducing systemic acquired resistance but is required in signal transduction," Plant Cell 6 959-965 (1994) It has been reported that a phloem-mobile signal may move from the necrotic leaf to the rest of the plant to establish SAR. Jennes, A. and Kuc', J, "Graft transmission of systemic resistance of cucumber to anthracnose induced by Colletotrichum lagenarium and tobacco necrosis virus," Phytopathology 69 753- Printed from Mimosa WO 98/51801 PCT/US98/09863 3 756 (1979), Guedes, et al, "Induced systemic resistance to anthracnose in cucumber as influenced by the location of the inducer inoculation with Colletotrichum lagenartum and the onset of flowering and fruiting," Physiol Plant Pathol 17 229-233 (1980), Tuzun, S and Kuc', J , "Movement of a factor in tobacco infected with Peronospora tabacma Adam which systemically protects against blue mold," Physiol Plant Pathol 26 321-330 (1985) A study using 180-labeling of tobacco mosaic virus (TMV)-inoculated tobacco leaves revealed that a large percentage of the salicylic acid in the systemic leaves is synthesized in the initially infected leaf, consistent with salicylic acid itself being the mobile SAR signal Shulaev, et al, "Is salicylic acid a translocated signal of systemic acquired resistance in tobacco," Plant Cell 1 1691-1701 (1995) However, other studies using cucumber (Rasmussen, et al, "Systemic induction of salicylic acid accumulation in cucumber after inoculation with Pseudomonas syrmgaepv syringae," Plant Physiol 97 1342-1347 (1991)), or grafting experiments with transgenic tobacco containing the bacterial NahG salicylic acid hydroxylase gene (and therefore exhibiting drastically reduced levels of salicylic acid), have led to the suggestion that salicylic acid is not the mobile signal For example, NahG rootstocks, when inoculated with TMV, are capable of producing a phloem-mobile signal that can be perceived in the wild-type scion, which then becomes resistant to subsequent pathogen challenge GafFney, et al, "Requirement of salicylic acid for the induction of systemic acquired resistance," Science 261 754-756 (1993) These results suggest that salicylic acid is not required in the induction/immunization phase of SAR The second stage in the signal transduction pathway that leads to SAR is the establishment stage, which involves the perception of the mobile signal in systemic leaves It is characterized by the expression of the same set of SAR genes as induced around the primary necrotic lesion, as well as the accumulation of salicylic acid, although to lower levels than are induced m the primary leaf during the induction stage The final stage in the signal transduction pathway is the expression stage which occurs when the plant is challenged with a second, normally virulent, Printed from Mimosa / / U.WU*. 4 pathogen and responds to that pathogen as if it were an avirulent one. Kuc', J Bioscience 32.854-856 (1982).
Recent studies using plants with very low levels of salicylic acid due to the expression of the NahG salicylic acid hydroxylase gene product (Ga£5iey, et al.. Science 261:754-756 (1993); Vernooij, et al., Plant Cell 6:959-965 (199^); Delaney, et al.. Science 266:1247-1250 (1994)) have shown that salicylic acid is required not oni> in the establishment and expression stages of SAR, but also during incompatible HR interactions, and even during compatible interactions to limit disease spread. The Arabidopsis SAR-defective mutants niml (Delaney. et a!.. Science 266-1247-1250 (1994)) and nprl (Cao, et al, "Characterization of an Arabidopsis mutant that is nonresponsive to inducers of systemic acquired resistance." Plant Cell 6:1583-1592 (1994)) also show enhanced disease susceptibility to virulent pathogens, confirming the role of salicylic acid in general disease resistance. Mutant cprl plants (constitutive expressor of PR genes) with elevated levels of SAR gene expression and salicylic acid were shown to be resistant to normally virulent pathogens (Bowling, et al., "A mutation in Arabidopsis that leads to constitutive expression of systemic acquired resistance," Plant Cell 6 1845-1857 (1994)), providing further genetic evidence in support of the importance of salicylic acid accumulation in disease resistance.
As outlined above, a number of Arabidopsis mutants affected in their ability to establish SAR have been isolated. However, these mutants also have a reduced general defense response, and therefore, the lesion in these plants is not s»pecific for SAR.
According to the present invention. Lipid Transfer Proteins (LTP's) have also been identified as important in the establishment of SAR in plants Previously, LTP's have been cloned from a number of plant species, and have been proposed to function in a range of processes including embryogenic development and eplcuticulair wax deposition (Pyee and Kolattukudy. "The gene for the major cudcular wax-associated protein and three homologous genes from broccoli (Brassica oleracea) and their expression patterns," Plant Journal 7: 49-59 (1995), Toonen et al., "AtLTPl luciferase expression during carrot somatic embrvogenesis," Plant Journal 12: 1213-1221 (1997)). In relation MENDED SHEET WO 98/51801 PCT/US98/09863 to the present invention, LTPs have already been implicated in plant defense responses Thus, LTPs from two monocot species were shown to possess antimicrobial activity (Molina et al, "Lipid transfer proteins (nsLTPs) from barley and maize leaves are potent inhibitors of bacterial and fungal plant pathogens," FEBS Letters 316 119-122 (1993)), and transgenic tobacco and Arabidopsi s genetically engineered to express a barley LTP were shown to exhibit enhanced tolerance against pathogens (Molina and Garcia-Olmedo, "Enhanced tolerance to bacterial pathogens caused by the transgenic expression of barley lipid transfer protein LTP2," Plant Journal 12 669-675 (1997)) These lipid transfer proteins have not been shown to function in SAR signal transduction Previous screens for SAR mutants have bypassed the initial signal production steps involved in SAR by inducing SAR through the plant by spraying with 2,6-dichloroisonicotinic acid (INA), which has been shown to act at the same point as, or even downstream of, salicylic acid in the SAR signal transduction pathway Despite reports concerning the possible role of salicylic acid in SAR, and the reported correlation of SAR gene expression with SAR, there is virtually no information available on the molecular mechanisms that result in the induction, transmission and expression of SAR Thus, there was a need for the isolation and characterization of the genes that are a part of the SAR signal transduction pathway, which encode for proteins which act upstream of the site of action of salicylic acid It has now been found that genes which code for proteins which act upstream from salicylic acid in the signal transduction pathway affect SAR in plants, and a method for isolating those genes is herein disclosed In particular, the dir-1 gene, which encodes a novel lipid transfer protein which is involved in the signal transduction pathway, has now been isolated and characterized The gene is useful as a reagent for determining the mechanisms involved in establishing SAR m plants, and for genetically engineering disease-resistance in plants A method for genetic screening of SAR mutants has also been developed which allows for detection of SAR-defective mutants throughout the SAR signal transduction Printed from Mimosa WO 98/51801 PCT/US98/09863 6 pathway, and more specifically, for those SAR mutants which encode proteins which act upstream of where salicylic acid acts in the SAR signal transduction pathway Proteins translated from the genes are useful for the production of antibodies to the proteins The antibodies are useful as reagents in screening plants for examples of the SAR signal transduction genes SUMMARY OF THE INVENTION The present invention is directed to a nucleic acid molecule encoding a protein capable of enhancing systemic acquired resistance in a plant The protein acts upstream from where salicylic acid acts along the signal transduction pathway The invention is also directed to a vector nucleic acid comprising the dir-1 gene The invention further comprises plant cells transformed with a vector containing the dir-1 gene This invention further comprises a method for conferring systemic acquired resistance to a plant The invention also comprises a method for isolating SAR mutants which encode proteins which act upstream of salicylic acid in the signal transduction pathway These and other features, aspects and advantages of the present invention will become better understood with reference to the following description and appended claims BRIEF DESCRIPTION OF THE DRAWINGS Fig 1 depicts the nucleotide sequence of the dir-1 gene Fig 2 depicts the amino acid sequence of the dir-1 lipid transfer protein DETAILED DESCRIPTION The present invention involves the isolation of genes involved in SAR signal transduction which encode proteins which act upstream from where salicylic acid acts along the SAR signal transduction pathway To isolate a gene involved in Printed from Mimosa WO 98/51801 PCT/US98/09863 7 SAR signal transduction which encodes a protein which acts upstream from where salicylic acid acts along the pathway, the following method is used Using techniques as described in Example 1, wild type and T-DNA transformed plants are grown and observed for disease symptoms SAR mutants are isolated, and SAR competence tests are performed as described in Example 1 The SAR mutants are then tested to determine the position of the mutant gene in relation to the point of salicylic acid action in the pathway as described in Example 1 DNA is isolated from those plants which are homozygous for a SAR mutant gene, and where the gene is found to encode a protein which acts upstream from the site of salicylic acid action along the pathway, probed to isolate a cDNA, and sequenced using techniques as described in Example 2 The isolated genes, such as the dir-1 gene, can be used as vectors to transform plants for improved disease resistance by restoring or enhancing SAR The plants to which the invention can be applied include the commercially important forage legumes such as but not limited to alfalfa, large-seeded legumes (grain legumes) such as but not limited to soybeans, beans, and peas, but not limited to solanaceous species such as tobacco, potato and tomato, and monocots such as but not limited to corn, wheat, and rice Transformation may be accomplished by any known means including Agrobacterium (Shargool, Peter D and Ngo, That T , Biotechnological Applications of Plant Cultures, 1994, pp 61-76 ), biohstic process (Shargool and Ngo at p 38) or electroporation Transformed plants may be regenerated by standard protocols well known to those with average skill in the art, such as organogenesis from leaf discs or somatic embryogenesis The transformed plants may be propagated sexually, or by cell or tissue culture The invention includes the expression of the proteins translated from the isolated genes such as the dir-1 gene These proteins, such as the dir-1 lipid transfer protein (dir-1 LTP), are useful in developing antibodies to the protein The antibodies are valuable reagents to be used in the process of screening plants for the expression of isolated genes such as the dir-1 gene To isolate a protein from a SAR signal transduction pathway gene, the gene product of the isolated gene is expressed as described in Example 5. Antibodies to the protein are Printed from Mimosa WO 98/51801 PCT/US98/09863 8 produced as described in Example 6 The antibodies to the protein are used as reagents for screening of plants for expression of the isolated gene as descnbed in Example 6 This invention includes a method for screening SAR-defective mutants throughout the SAR signal transduction pathway, and, more specifically, for screening for those mutants of genes which encode proteins which act upstream from where salicylic acid acts along the pathway After transforming plants and then observing those plants for disease symptoms as descnbed in Example 1, SAR mutants are isolated The SAR mutants are then tested to determine the position of the mutant gene in relation to the point of salicylic acid action in the pathway as described in Example 1 EXAMPLE 1 Isolation and characterization of dir-1 mutant Plant and Bacterial Growth Conditions Arabidopsis thahana ecotype Wassilewskija (Ws) and the Feldman T-DNA transformed seed pools (Arabidopsis Biological Resource Center at Ohio State University) were stenlized, plated on Murashige minimal organics media, then transferred to soil after ten days as previously descnbed Cameron et al, Plant J 5 715-725 (1994) Plants were placed in growth chambers at 22 to 24°C at a light intensity of 150 //E m"2 sec"1 with a nine hour photoperiod, and grown for 4-5 weeks. Pseudomonas syringaepv tomato (Pst) strains DC3000[pLAFR3] (virulent) and DC3000[pLAFR3+avrRpt2] (avirulent) (Whalen, et al, "Identification of Pseudomonas syringae pathogens of Arabidopsis and a bacterial locus determining avirulence on both Arabidopsis and soybean," Plant Cell 3 49-59 (1991)) and Pspv macuhcola M4[pLAFR3+avrRpml] (avirulent) (Debener, et al, "Identification and molecular mapping of a single Arabidopsis thaliana locus determining resistance to a phytopathogenic Pseudomonas syringae isolate," Plant J1 289-302 (1991)) were grown as previously descnbed Cameron et al, Plant J 5 715-725 (1994) Printed from Mimosa WO 98/51801 PCT/US98/09863 9 Isolation of SAR Mutants Four to five week old T-DNA mutagemzed plants (Ml generation) were given an immunizing inoculation of avirulent Pst (107 cfii/ml) on one leaf per plant, then two days later, challenge inoculated on three other leaves with virulent Pst (5x105 cfu/ml) Plants were observed four to five days later and symptoms compared to control avirulent (SAR induced) and virulent treatments performed on ecotype Ws Those plants showing disease symptoms were selected as potential SAR mutants and allowed to set seed Between 30 and 40 progeny of the putative SAR mutants were rescreened in the M2 generation as described below Genetic Characterization of dir-1 A number of dir-1 M2 plants were backcrossed to wild-type Ws and the resulting Fl, F2, and F3 progeny subjected to a SAR competence test (described below) in order to determine whether the dir-1 mutation was recessive or dominant to wild-type, and also if the dir-1 phenotype cosegregated with the T-DNA (kanamycin resistance marker) SAR Competence Test Both dir-1 and wild-type Ws plants were subjected to a number of infection treatments The control treatment (M,M) consisted of a primary inoculation with 10 mM MgCl2 on one leaf per plant, followed two days later by another inoculation with 10 mM MgCl2 on four other leaves/plant An avirulent treatment (M,A) consisted of a primary inoculation with 10 mM MgCl2 on one leaf per plant, followed two days later by an avirulent inoculum (106 cfu/ml) on four other leaves/plant A virulent treatment (M,V) consisted of a primary inoculation with 10 mM MgCl2 on one leaf/plant, followed two days later by a virulent inoculum (106 cfu/ml) on four other leaves per plant A SAR treatment (A,V) consisted of a primary inoculation with avirulent bacteria (106 cfu/ml) on one leaf/plant, followed two days later with a virulent inoculum (106 cfu/ml) on four other leaves/plant Printed from Mimosa WO 98/51801 PCT/US98/09863 Disease symptoms or their absence were noted for each treatment, and results confirmed by collecting leaf discs from each treatment for determination of in planta bacterial growth Quantification of Bacterial Growth in planta Eight leaf discs (4 0 mm in diameter) were harvested from individual plants and macerated in 10 mM MgCl2 Appropriate dilutions were made in 10 mM MgClz and plated on King's B agar (King, et al, "Two simple media for demonstration of phycocyanin and fluorescein," J Lab Clin Med 44 301-307 (1954)) containing 100 mg/1 rifampicin (Sigma Chemical Co, St Louis, MO ) and 20 mg/1 tetracycline (Sigma) to prevent growth of bacteria other than those used as inoculum Analysis of Salicylic Acid Levels Salicylic acid was determined by grinding 0 5 g of Arabidopsis leaf tissue (20-30 leaves) in liquid N2, then extracting in 50% ethanol plus 0 04% 2-mercapto-ethanol, followed by two volumes of 100% ethanol plus 0 04% 2-mercaptoethanol The combined ethanol extracts were dried under N2, until approximately 4 ml of water remained, then extracted two times with one volume of ethyl acetate The ethyl acetate phase was dried under N2, and the dried material resuspended in 200 /A of 100% methanol Salicylic acid was quantified by reverse phase HPLC Samples (20 fj.1) were injected onto a 4 6 x 250 mm 5 /u.m C-18 silica column (J T Baker, Inc, Philhpsburg, NJ), equilibrated at ambient temperature with 95% 20 mM sodium acetate, pH 5 0, 5% methanol, and run isocratically at a flow rate of 1 5 ml/min Salicylic acid (retention time approximately 7 min) was detected using a scanning fluorescence detector (Model FP-920, JASCO, Easton, MD) with excitation at 315 nm and emission at 405 nm, as described by Yalpani, et al. (1991) The identity of salicylic acid peaks from representative samples was confirmed by comparison of the emission spectra with that of an authentic salicylic acid standard Salicylic acid peaks were also confirmed by digesting a number of previously determined salicylic acid samples with salicylic acid hydroxylase (Sigma) Printed from Mimosa WO 98/51801 PCT/US98/09863 11 and demonstrating that the salicylic acid peaks disappeared after this treatment Total salicylic acid (free salicylic acid + glucose conjugate) was measured by digesting 50 (A of the methanol extracts with P-glucosidase The loss of salicylic acid during the extraction procedure varied from 36 to 50% and was corrected for during the calculation of salicylic acid levels (ng/g fwt) RNA Extraction and Analysis RNA was isolated from frozen leaf samples (3-4 leaves/sample) using the small scale procedure of Verwoerd, et al, "A small scale procedure for the rapid isolation of plant RNAs," Nucleic Acids Res 17 23 8 2 (1989) Samples of total RNA (5 fj.g) were separated by electrophoresis through formaldehyde-agarose gels and blotted to Hybond-N nylon membranes (Amersham Corp , Arlington Heights, IL) as described in Sambrook, et al, Molecular Cloning, A Laboratory Manual, 2nd ed , Cold Spring Harbor Laboratory Press, pp 7 43-7 46(1989) Ethidium bromide (40 Mg/ml) was included in the sample buffer in order to confirm equal sample loading under UV light after electrophoresis Arabidopsis cDNA clones for PR-1, PR-2 and PR-5 (Uknes, et al, Plant Cell 4 645-656 (1992)) were 32P-labeled by random priming using a Random Primer Kit (Amersham) Hybridizations and washes were carried out according to Church, G M and Gilbert, W , "Genomic sequencing," Proc Natl Acad Set USA 81 1991-1995 (1984) A rDNA probe was used to reconfirm that each lane was loaded with similar levels of total RNA Isolation and Genetic Characterization of the Arabidopsis dir-1 Mutant Of 11,000 T-DNA transformed (MI) plant lines screened, 200 putative SAR mutants were recovered After retesting in the M2 generation, the dir-1 gene proved to be a true SAR defective mutant In two separate SAR tests of M2 dir-1 plants, the SAR defective phenotype segregated with a ratio of 3 1 (chi square values p>0 9 and p>0 8) for SAR defective to SAR competent (wild-type) plants These results indicate that the dir-1 mutation is dominant to the wild-type SAR gene function Printed from Mimosa WO 98/51801 PCT/US98/09863 12 Three different M2 dir-1 plants were backcrossed to the wild-type Ws background in order to confirm the dominant nature of the dir-1 mutation The progeny (approximately ten plants) of each cross were tested again for SAR competence (see Table 1 for data on bacterial growth in planta) All the progeny from each cross were SAR defective, confirming the dominant nature of the dir-1 mutation Table 1 Bacterial Growth in planta (cfu/leaf disc) for dir-1 x Ws F3 progeny1 Treatment2 Genotype Control Avirulent Virulent SAR (M,M) (M,A) (M,V) (A,V)3 (A,V)4 Ws 102 8x10s 5xl07 2 2x106 2xl06 dir-1 F2-a 2xl02 6 4x105 4 6xl07 8 OxlO7 3 7x107 dir-1 F2-b 5x 102 8 7x105 2 8x107 3 2xl07 - 1 Eight leaf discs (2 replicates) were collected from each treatment, the average of 2 replicates is presented 2 (M,M) - Primaiy inoculation - MgCl2, 2nd challenge inoculation -MgCl2 (M,A)- Primary inoculation - MgCl2; 2nd inoculation -avirulent Pst, collect inoculated or umnoculated leaves after 2nd challenge (M,V) - Primary inoculation - MgCl2,2nd inoculation - virulent Pst, collect inoculated leaves after 2nd challenge (A,V) - Primary inoculation - avirulent Pst, 2nd inoculation - virulent Pst, collect inoculated leaves after 2nd challenge 3 (A,V), A= PstavrRpt2 4 (A,V), A= PsmavrRpml The backcrossed dir-1 lines were allowed to set seed and were plated out (250-500 seeds) on kanamycin-contairung media to determine if the SAR defective phenotype segregated with the kanamycin resistance gene present on the T-DNA to determine whether the dir-1 mutation was the result of insertion of the T-DNA Printed from Mimosa WO 98/51801 PCT/US98/09863 13 into the dir-1 gene Seven backcrossed F2 lines were analyzed Segregation ratios (kanamycin resistant to kanamycin sensitive) ranged from 7 to 3 3, indicating that there was at one time more than one T-DNA insertion per plant If there were two functional copies of the T-DNA present in these lines, the ratio of kanamycin resistant to sensitive plants would be 15 1 These F2 lines (kanamycin resistant and sensitive) were transferred to soil, grown for four weeks, then tested for SAR competence by measurement of disease symptoms and bacterial growth levels Very few of the kanamycin sensitive plants grew when transferred to soil, but for the most part, these plants were SAR competent Plants from the F2 lines which grew on kanamycin ranged from 100% SAR defective as expected to 80% SAR defective, indicating that there was a functional kanamycin resistance gene in some of the progeny that was not linked to the dir-1 mutation DNA was isolated from both SAR defective, kanamycin resistant F2 plants and from SAR competent, kanamycin sensitive F2 plants The DNA from each sample was digested with EcoRl and subjected to electrophoresis, blotting, and probing with the plasmid pBR322, which is contained within the T-DNA construct Errampalli, et al, "Embryonic lethals and T-DNA insertional mutagenesis in Arabidopsis," Plant Cell 3 149-157 (1991) A number of the F2 SAR defective, kanamycin resistant plants contained bands corresponding to the T-DNA that were not found in the SAR competent, kanamycin sensitive plants A number of these dir-1 F2 kanamycin resistant plants were backcrossed again to wild-type Ws in order to eliminate any non-linked T-DNA sequences A number of the F2 families of the dir-1 x Ws backcross segregated 3 1 for kanamycin resistance A SAR competence test was performed on individuals from two families that grew on kanamycin-containing media, if the T-DNA cosegregates with the dir-1 phenotype, all individuals are SAR defective Each individual in both families (approximately 120) was SAR defective as measured by phenotype and bacterial quantification These results confirm that the dir-1 mutant phenotype was segregating with kanamycin resistance and the T-DNA insertion F3 seed from a number of F2 individuals was collected and was used to isolate dir-1 homozygous plants All kanamycin sensitive F3 plants were homozygous wild-type Printed from Mimosa WO 98/51801 PCT/US98/09863 14 for dir-1, and expressed SAR The genetic analysis therefore indicates that the dir-1 mutation is caused by the insertion of a T-DNA, facilitating the strategy of cloning the interrupted gene by polymerase chain reaction (PCR) techniques Rescue of the dir-1 Phenotype with INA Spraying Arabidopsis with 2,6-dichloroisonicotinic acid (INA), can induce SAR to virulent fungal and bacterial pathogens Uknes, et al, Mol Plant-Microbe Interact 6 692-698 (1993) INA is thought to act at the same point or downstream of salicylic acid in the SAR signal transduction pathway (Vernooij et al, 1995) Therefore, dir-1 M2 plants were sprayed with INA and then challenged four days later with 106 cfu/ml of virulent bacteria, the plants were observed three days later and the symptoms recorded The virulent control treatment (M,V) produced disease symptoms on both Ws and dir-1 plants, whereas the SAR treatment (A,V) produced disease in the dir-1 plants and resistance or SAR in the Ws plants Both wild-type Ws and dir-1 plants that were sprayed with INA then challenged with virulent bacteria remained symptomless, indicating that INA induced SAR in dir-1 plants This demonstrates that the dir-1 mutation is upstream of INA in the SAR signal transduction pathway Substances such as, but not limited to, aspirin (acetylsalicyhc acid), methysalicylate, and benzothiazoles which, like INA, mimic the effects of salicylic acid, may also be used SAR Gene Expression and Salicylic Acid Levels in the Arabidopsis dir-1 Mutant In preliminary studies of dir-1 x Ws F2 progeny (kanamycin resistant, SAR defective) following inoculation with avirulent Pst (SAR treatment), expression of the SAR genes PR-1, PR-2 and PR-5 was reduced in the expression stage of SAR as compared to wild-type plants However, salicylic acid accumulated to similar or higher levels than observed in wild-type plants (Table 2), consistent with earlier findings which show that salicylic acid accumulation is involved not only in SAR, but also in the hypersensitive response (HR) and general defense responses in Arabidopsis Delaney, et al, Science 266 1247-1250 (1994), Cameron et al, Printed from Mimosa WO 98/51801 PCT/US98/09863 unpublished) Moreover, SAR was not induced in the dir-1 mutant when a different avirulent bacterium (Psm M4 avrRpml) was used as the immunizing primary inoculum, further indicating that the lesion in the dir-1 mutant plants is specific for the SAR signal transduction pathway Table 2 Free Salicylic Acid (ng/gfw) in Ws and dir-1 (F2 progeny) Genotype Control Induction Establishment Expression (M,M-inoc)' (M,A-inoc)2 (M,A-uninoc)3 (A,V-moc)4 Ws 95 1750 105 1186 dir-1 F2-a 93 2195 176 2500 dir-1 F2-b - 1257 167 1017 1 (M,M-inoc) - Primary inoculation - MgCl2, 2nd challenge inoculation -MgCl2, salicylic acid levels were determined for leaves collected from the 2nd inoculation 2'3 (M,A)- Primary inoculation - MgCl2, 2nd inoculation - avirulent Pst, collect moc or uninoc leaves after 2nd challenge 4 (A,V) - Primary inoculation - avirulent Pst, 2nd inoculation -virulent Pst, collect inoculated leaves after 2nd challenge EXAMPLE 2 Isolation and Characterization of the dir-1 Gene Genomic DNA was isolated from leaves of a dir-1 homozygous line by standard procedures (Sambrook, et al, Molecular Cloning, A Laboratory Manual, 2nd ed , Cold Spring Harbor Laboratory Press (1989) Application of thermal assymetnc interlaced (TAIL) PCR (Liu et al, "Efficient isolation and mapping of Arabadopsis thaliana T-DNA insert junctions by thermal assymetnc interlaced PCR", Plant Journal 8 457-463 (1995)) using primers specific for the right border (RB) of the T-DNA resulted in cloned sequences containing the RB but, instead of plant flanking DNA, inverted T-DNA sequences were found, indicating that a rearrangement had occurred within the T-DNA leading to an insert with two left borders (LBs) TAIL-PCR was then performed using primers designed to anneal to Printed from Mimosa WO 98/51801 PCT/US98/09863 16 the LB of the T-DNA Two specific sequences were amplified, consisting of LB and plant genomic flanking sequences A combination of PCR and Southern blot analysis with genomic DNA from wild-type and dir-1 Arabidopsis indicated that the two sequences amplified by TAIL-PCR were contiguous in the genome of wild-type Arabidopsis, and were interrupted by the single T-DNA insertion This insertion was in the 3' untranslated region of a gene, the open reading frame of which had significant sequence identity to that of a non-specific lipid transfer protein (LTP) from Phaseolus vulgaris Sequencing the flanking DNA beyond the T-DNA insertion (away and out from the 3'-end of the LTP) revealed no open reading frame in over 1 1 KB of sequence Furthermore, the LTP transcript levels were strongly reduced in total RNA preparations from the dir-1 line, suggesting that the T-DNA insertion does indeed interfere with the expression of the dir-1 gene Probes from the genomic LTP sequence were used to isolate a cDNA encoding the complete LTP using standard methods (Sambrook, et al, Molecular Cloning, A Laboratory Manual, 2nd ed , Cold Spring Harbor Laboratory Press (1989)) DNA Sequence Analysis DNA was sequenced by the Sanger dideoxy sequencing method (Sanger, et al, Proc Natl Acad Sci USA 74 5463-5467 (1977)) A Taq Dideoxy Terminator Cycle Sequencing Kit (Applied Biosystems Inc , Foster City, CA) was used according to the manufacturer's protocol The products were separated on a 6% polyacrylamide gel and the data processed by an ABI 373A automated DNA sequencer All manipulations of raw data generated from the automated system were done on the PC Gene DNA analysis software (Intelligenetics, Mountain View, CA) The nucleotide sequence is shown in SEQ ID NO 1 Evidence indicates that the Arabidopsis LTP encoded by dir-1 is a novel protein involved in signal transduction for establishing systemic plant immunity to disease Firstly, the nature of the genetic screen targeted mutations in systemic rather than local responses, and this was borne out by the fact that the dir-1 Printed from Mimosa WO 98/51801 PCT/US98/09863 17 mutation does not affect the local response to avirulent pathogens or the level of susceptibility to virulent pathogens in naive plants, as would occur if the dir-1 gene product was in itself antimicrobial Secondly, inducers of SAR such as INA rescue the dir-1 phenotype, indicating that dir-1 is upstream of other signal functions such as nprl, mutations which eliminate responsiveness to INA (Cao et al, "Characterization of an Arabidopsis mutant that is nonresponsive to inducers of systemic acquired resistance," Plant Cell 6 1583-1592 (1994)) Thirdly, systemic induction of pathogenesis-related (PR) proteins and micro-HRs, molecular markers for the establishment of SAR in systemic leaves (Cao et al, "Characterization of an Arabidopsis mutant that is nonresponsive to inducers of systemic acquired resistance," Plant Cell 6 1583-1592 (1994), Alvarez et al, "Reactive oxygen intermediates mediate a systemic signal network in the establishment of plant immunity," Cell 92 773-784 (1998)) is suppressed in dir-1 The T-DNA insertion in the 3'-untranslated region of dir-1 leads to a reduction in corresponding transcript levels and therefore reduced levels of functional dir-1 LTP This, in turn, blocks signal transduction from the primary infected leaf to systemic leaves of the plant The identification of the dir-1 gene having dir-1 LTP as a translation product indicates that lipid intermediates act as systemic signals in SAR The amino acid sequence for the dir-1 LPT was derived using PC Gene software and is given in SEQ ID NO 2 EXAMPLE 3 Construction of a vector containing the dir-1 gene Fragments containing the full length Arabidopsis dir-1 cDNA, or a functional homolog of dir-1 from another plant species, are cloned m a binary vector plasmid, for example in place of the GUS gene in the binary vector plasmid pBI121 1 (R A Jefferson, T A Kavanagh, M W Bevan, "GUS fusions 13-glucuromdase as a sensitive and versatile gene fusion marker in higher plants," The EMBRO Journal 6 3901-3907 (1987), under the control of the cauliflower mosaic virus 35S promoter (or any other constitutively expressed or inducible promoter Printed from Mimosa 18 active in plant cells) and the nopaline synthase terminator (or any other transcriptional termination signal active in plant cells) Cloning and vector construction uses standard recombinant DNA techniques in E coh strains HB101 or DH5a, performed according to (Sambrook, J , Fntsch, E F & Maniatis, T (1989) Molecular Clomng A Laboratory Manual (2nd Ed), Cold Spring Harbor Laboratory Press, New York) Orientations of the insert are confirmed by restriction mapping, and the 5' ends of each construct confirmed by sequencing from an oligonucleotide primer from the 35S promoter or other promoters know to be used in the art EXAMPLE 4 Use of dir-1 gene vector in the transformation of plants and creation of transgenic plants Tobacco and alfalfa plants are transformed with A. tumefaciens strain LBA4404 harbonng the dir-1 gene construct by leaf disc methods Transgenic tobacco plants (Nicotiana tabacum cv Xanthi NF) are generated as described before (Rogers, et al, "Gene transfer in plants Production of transformed plants using Ti plasmid vectors," Methods Enzymol 118 627-640 (1986)), with regeneration under kanamycin selection Transgenic alfalfa plants are generated from the transformation and regeneration of competent alfalfa cultivar Regen SY (Bingham, E T , "Registration of alfalfa hybrid Regen-SY germplasm for tissue culture and transformation research," Crop Sci 31 1098 (1991)), following a modified version of published procedures (Bingham, et al, "Breeding alfalfa which regenerates from callus tissue in culture," Crop Sci 15 719-721 (1975)) Briefly, leaf discs from young trifoliate leaves are inoculated with a suspension of Agrobacterium harboring the binary construct and incubated on solid B5h plates (Brown, O C W and Atanassov, A, "Role of genetic background m somatic embryogenesis in Medicago," Plant Cell Tiss Organ Cult 4 111-122 (1985)) for four days (16 hours light at 24 °C) The explants are then washed twice with water to remove bacteria and incubated for four more days on new B5h plates Explants are then washed twice with water and transferred to selection plates (B5h plates Printed from Mimosa WO 98/51801 PCT/US98/09863 19 with 100 mg/L timentin (Smith-Kline Beecham, Philadelphia, PA) and 25 mg/L kanamycin (Sigma, St Louis, MO)) Calli and occasional embryos appear after two weeks and are transferred to new selection plates, making sure the calli are spread out Plates are incubated for another week to allow development of additional embryos The calli and embryos are then transferred to B5 plates (no hormones, but with antibiotics as before) After two weeks, the calli and embryos are transferred to fresh B5 plates (with antibiotics) After one to two weeks, individual embryos are cultured on MS plates (Murashige, T , and Skoog, F , "A revised medium for rapid growth and bioassays with tobacco tissue culture," Physiol Plant 15 473-497 (1962)) with antibiotics (50 mg/L timentin and 25 mg/L kanamycin), plantlets are formed within one to three weeks, occasionally with roots These are transferred to plastic boxes (Magenta Corp, Chicago, IL) with MS agar media and antibiotics Plants are maintained on MS media with antibiotics and propagated by cutting Plants are also transferred to soil in the greenhouse EXAMPLE 5 Isolation of the dir -1 LTP The Arabidopsis dir-1 gene product is expressed in E coh SB221 cells as described (BS Shorrosh and RA Dixon, "Molecular cloning of a putative plant endomembrane protein resembling vertebrate protein disulfide isomerase and phosphatidylinositol-specific phospholipase C," Proc Natl Acad of Sci USA 88 10941-10945) The expressed protein is resolved by polyacrylamide gel electrophoresis (Laemmli, U K, "Cleavage of structural proteins dunng the assembly of the head of bacteriophage T4, Nature 227 680-685 (1970)) The protein band encoded by dir-1 is localized by staining with Coomassie brilliant blue, and regions from 12 gel lanes excised, cut into small fragments, destained to completion with 50% (v/v) isopropanol/3% (w/v) SDS overnight, rinsed with water, vacuum dned, ground in liquid nitrogen, and finally resuspended in phosphate buffered saline Printed from Mimosa WO 98/51801 PCT/US98/09863 EXAMPLE 6 Production and use of antibodies to the dir-1 LTP protein Antiserum is obtained by immunizing a female New Zealand White rabbit The primary immunization contains approximately 30 /Ug of the dir-1 LTP in 2 7 ml of complete Freund's adjuvant, injected subcutaneously along the back at nine separate sites (300 ml per site) Booster injections containing dir-1 LTP from six excised gel lanes (approximately 15^g) in incomplete Freund's adjuvant are given at 4 and 6 weeks after the primary injections The serum is stored at - 20°C The antibodies are used as a reagent to detect the dir-1 LTP m transgenic plants in a Western blot analysis Leaf and stem proteins are extracted in 0 2 M borate buffer, pH 8 8 and subjected to denaturing polyacrylamide gel electrophoresis by standard procedures (Ausubel et al 1994 Current Protocols in Molecular Biology, John Wiley and Sons, Inc , New York) Proteins are transferred to Immobilon-P membranes (Milhpore, Milford, MA) in 25 mM Tris-HC1, pH 8 3, 192 mM glycine, and 20% methanol (Towbin et al 1979 "Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets procedure and some applications," Proc Natl Acad Sci USA 9 4350-4354) Membranes are blocked and probed with primary (anti-dir-1) and secondary antibodies, e g , goat anti-rabbit IgG linked to a detection system such as alkaline phosphatase, in 3% BSA in TTBS (0 1% Tween-20 in Tris-bufFered saline) (Ausubel et al, Current Protocols in Molecular Biology (1994)) Although the present invention has been described in considerable detail with reference to certain preferred versions thereof, other versions are possible Therefore, the spirit and scope of the appended claims should not be limited to the description of the preferred versions contained herein Printed from Mimosa 21 SEQUENCE LISTING (1) GENERAL INFORMATION: (i) APPLICANT: (A) NAME: The Samuel Roberts Noble Foundation, Inc.
(B) STREET: P.O. Box 2180 (C) CITY: Ardmore (D) STATE: Oklahoma (E) COUNTRY: US (F) POSTAL CODE (ZIP): 73402 (G) TELEPHONE: 580-223-5810 (H) TELEFAX: 580-221-7380 (i) APPLICANT: (A) NAME: Dixon, Richard A.
(B) STREET: 206 Woods Lane (C) CITY: Ardmore (D) STATE: Oklahoma (E) COUNTRY: US (F) POSTAL CODE (ZIP): 73401 (G) TELEPHONE: (H) TELEFAX: (i) APPLICANT: (A) NAME: Cameron, Robin (B) STREET: 207 Lee Avenue (C) CITY: Toronto (D) STATE: Ontario (E) COUNTRY: CA (F) POSTAL CODE (ZIP): M4E 2P4 (G) TELEPHONE: (H) TELEFAX: (i) APPLICANT: (A) NAME: Lamb, Christopher J.
(B) STREET: 6444 Farley Drive (C) CITY: San Diego (D) STATE: California (E) COUNTRY: US (F) POSTAL CODE (ZIP): 92122 (G) TELEPHONE: (H) TELEFAX: (ii) TITLE OF INVENTION: Gene Encoding for Systemic Acquired Resistance in Arabidopsis (iii) NUMBER OF SEQUENCES: 2 (IV) CORRESPONDENCE ADDRESS: (A) ADDRESSEE: Sidley & Austin (B) STREET: 717 N. Harwood, Suite 3400 (C) CITY: Dallas (D) STATE: Texas (E) COUNTRY: United States of America (F) ZIP: 75201-6507 (v) COMPUTER READABLE FORM: (A) MEDIUM TYPE: Floppy disk Printed from Mimosa WO 98/51801 PCT/US98/09863 22 (B) COMPUTER: IBM PC compatible (C) OPERATING SYSTEM: PC-DOS/MS-DOS (D) SOFTWARE: Patentln Release #1.0, Version #1.30 (vi) CURRENT APPLICATION DATA: (A) APPLICATION NUMBER: US (B) FILING DATE: (C) CLASSIFICATION: (viii) ATTORNEY/AGENT INFORMATION: (A) NAME: Hansen, Eugenia S.
(B) REGISTRATION NUMBER: 31,966 (C) REFERENCE/DOCKET NUMBER: 11137/03402 (ix) TELECOMMUNICATION INFORMATION: (A) TELEPHONE: 214-981-3315 (B) TELEFAX: 214-981-3400 (2) INFORMATION FOR SEQ ID NO:l: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 4 39 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (11) MOLECULE TYPE: cDNA (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 36..341 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:l: CAAACATATA GAAAAAGAGA GAGGAGGATA ATAAT ATG GCG AGC AAG AAA GCA 53 Met Ala Ser Lys Lys Ala 1 5 GCT ATG GCT ATG ATG GCG ATG ATC GTG ATA ATG GCT ATG TTG GTC GAT 101 Ala Met Ala Met Met Ala Met lie Val lie Met Ala Met Leu Val Asp 10 15 20 ACA TCA GTA GCG ATA GAT CTC TGC GGC ATG AGC CAG GAT GAG TTG AAT 149 Thr Ser Val Ala lie Asp Leu Cys Gly Met Ser Gin Asp Glu Leu Asn 25 30 35 GAG TGC AAA CCA GCG GTT AGC AAG GAG AAT CCG ACG AGC CCA TCA CAG 197 Glu Cys Lys Pro Ala Val Ser Lys Glu Asn Pro Thr Ser Pro Ser Gin 40 45 50 CCT TGC TGC ACC GCT CTG CAA CAC GCT GAT TTT GCA TGT CTT TGT GGT 245 Pro Cys Cys Thr Ala Leu Gin His Ala Asp Phe Ala Cys Leu Cys Gly 55 60 65 70 TAC AAG AAC TCT CCA TGG CTC GGT TCT TTC GGT GTT GAT CCT GAA CTC 293 Tyr Lys Asn Ser Pro Trp Leu Gly Ser Phe Gly Val Asp Pro Glu Leu 75 80 85 Printed from Mimosa WO 98/51801 PCT/US98/09863 23 GCT TCT GCT CTC CCC AAA CAG TGT GGT CTA GCC AAC GCC CCA ACT TGT 341 Ala Ser Ala Leu Pro Lys Gin Cys Gly Leu Ala Asn Ala Pro Thr Cys 90 95 100 TAAAAGACTC TCTGTATACG TGTGTTTATG TTTTTTATTA CTCCTATTCT AAATATCGGA 401 TGTTATTAAT AAATCGTATT TTCTGCCAAA AAAAAAAA 4 39 (2) INFORMATION FOR SEQ ID NO:2: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 102 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:2: Met Ala Ser Lys Lys Ala Ala Met Ala Met Met Ala Met lie Val lie 15 10 15 Met Ala Met Leu Val Asp Thr Ser Val Ala He Asp Leu Cys Gly Met 20 25 30 Ser Gin Asp Glu Leu Asn Glu Cys Lys Pro Ala Val Ser Lys Glu Asn 35 40 45 Pro Thr Ser Pro Ser Gin Pro Cys Cys Thr Ala Leu Gin His Ala Asp 50 55 60 Phe Ala Cys Leu Cys Gly Tyr Lys Asn Ser Pro Trp Leu Gly Ser Phe 65 70 75 80 Gly Val Asp Pro Glu Leu Ala Ser Ala Leu Pro Lys Gin Cys Gly Leu 85 90 95 Ala Asn Ala Pro Thr Cys 100 Printed from Mimosa
Claims (51)
1. A nucleic acid molecule which encodes a lipid transfer protein wherein the encoded lipid transfer protein exhibits SAR signal transducing property, said nucleic acid molecule obtained by a process comprising the steps of: a. growing wild type and T-DNA transformed plants and observing for disease symptoms; b. isolating SAR mutants showing disease symptoms; c. performing SAR competence tests to validate the SAR mutation in said SAR mutants, wherein SAR is compromised in a SAR mutant plant upon first being treated on one leaf of said plant with an avirulent inoculum and later being treated on other leaves of said plant with a virulent inoculum as compared to a wild type plant which exhibits SAR upon first being treated on one leaf with an avirulent inoculum and later being treated on other leaves with a virulent inoculum; d. testing said SAR mutants to determine the position of the mutant gene in relation to the point of salicylic acid action in the signal transduction pathway, wherein said SAR mutants which are first sprayed with substance that mimics salicylic acid and acts at about the same point as salicylic acid in the SAR signal transduction pathway, challenged with a virulent inoculum, and then remain symptomless exhibit a SAR mutant gene upstream of the point of salicylic acid action in the signal transduction pathway; e. isolating DNA from those plants which are homozygous for a SAR mutant gene, and where the gene is found to encode a protein which acts upstream from the site of salicylic acid action along the signal transduction pathway; and f. probing said DN'A to isolate cDNA.
2. The nucleic acid of claim 1, wherein said nucleic acid can function as a vector for plants, said nucleic acid encoding a lipid transfer protein which exhibits a SAR signal transducing property. AMENDED SHEET 25 INTELLECTUAL PROPERTY OFFICE OF N Z. 2 NOV 2001 R E C E! ¥ E D
3. The nucleic acid molecule of claim 1 or 2, wherein sbi4-enee4ed-lipid transfer protein is depicted in SEQ ID NO:2.
4. The nucleic acid molecule of claim 3, wherein said nucleic acid is purified cDNA.
5.The nucleic acid of claim 1 or 2, wherein said nucleic acid comprises nucleotides 36 to 341 as depicted in SEQ ID NO:l.
6.l"he nucleic acid of claim 5, wherein said nucleic acid is purified cDNA.
7. A vector comprising the nucleic acid molecule of claim 3
8. A vector comprising the nucleic acid molecule of claim 5
9. A transformed plant comprising the vector of claim 7.
10. A transformed plant comprising the vector of claim 8
11. A plant cell and plants transformed with a recombinant nucleic acid molecule which encodcs a lipid transfer protein, wherein said encoded lipid transfer protein exhibits SAR signal transducing property, wherein said recombinant nucleic acid molecule is obtained by a process comprising the steps of: a. growing wild type and T-DNA transformed plants and observing for disease symptoms; b. isolating SAR mutants showing disease symptoms; c. performing SAR competence tests to validate the SAR mutation in said SAR mutants, wherein SAR is compromised in a SAR mutant plant upon first mended sheet being treated on one leaf of said plant with an avirut^it inoculum and later being treated on other leaves of said plant with a virulent inoculum as compared to a wild type plant which exhibits SAR upon first being treated on one leaf with an avirulent inoculum and later being treated on other leaves with a virulent inoculum. 15 d. testing said SAR mutants to determine the position of the mutant gene in relation to the point of salicylic acid action in the signal transduction pathway, wherein said SAR mutants which are first sprayed with substance that mimics salicylic acid and acts at about the same point as salicylic acid in the SAR signal transduction pathway, challenged with a virulent inoculum, and then remain 20 symptomless exhibit a SAR mutant gene upstream of the point of salicylic acid action in the signal transduction pathway; e. isolating DNA from those plants which are homozygous for an SAR mutant gene, and where the gene is found to encode a protein which acts upstream from the site of salicylic acid action along the signal transduction pathway; and 25 f probing said DNA to isolate cDNA.
12. The plant cell and plants according to claim 11, wherein said recombinant nucleic acid molecule is integrated into the plant's chromosomal DNA.
13. The plant cell and plants according to claim 11, wherein said recombinant nucleic acid molecule comprises nucleotides 36 to 341 as depicted in SEQ ID NO:l.
14. A lipid transfer protein encoded by nucleotides 36-341 of SEQ ID NO:l.
15. A lipid transfer protein having an amino acid sequence as depicted in SEQ ID NO:2, wherein said protein exhibits SAR signal transducing property.
16. An antibody which specifically binds the protein of Claim 14 or 15. ,K,TtOFHCE OF 2 A SEP 2001 RECEIVED. 27
17. A method of conferring systemic acquired resistance to a plant comprising transforming said plant with a vcctor comprising a nucleic acid molecule encoding a lipid transfer protein exhibiting SAR signal transducing property, said nucleic acid molecule obtained by a process comprising the steps 5 of: a. growing wild type and T-DNA transformed plants and observing for disease symptoms; b. isolating SAR mutants showing disease symptoms; c. performing SAR competence tests to validate the SAR mutation in 10 said SAR mutants, wherein SAR is compromised in a SAR mutant plant upon first being treated on one leaf of said plant with an avirulent inoculum and iater being treated on other leaves of said plant with a virulent inoculum as compared to a wild type plant which exhibits SAR upon first being treated on one leaf with an avirulent inoculum and later being treated on other leaves with a virulent inoculum, 15 d. testing said SAR mutants to determine the position of the mutant gene in relation to the point of salicylic acid action in the signal transduction pathway, wherein said SAR mutants which are fiist sprayed with substance that mimics salicylic acid and acts at abouc the same point as salicylic acid in the SAR signal transduction pathway, challenged with a virulent inoculum, and then remain 20 symptomless exhibit a SAR mutant gene upstream of the point of salicylic acid action in the signal transduction pathway; e isolating DNA from those plants which are homozygous for an SAR mutant gene, and where the gene is found to encode a protein which acts upstream from the site of salicylic acid action along the signal transduction pathway; and 25 f. probing said DNA to isolate cDNA.
18. The method of Claim 17, wherein said nucleic acid region comprises nucleotides 36 to 341 as depicted in SEQ ID NO:l.
19. The method of Claim 18, wherein said protein has an amino acid sequence as depicted in SEQ ID NO:2 INTELLECTUAL PROPERTY OFFICE OF NZ 2 NOV 2001 AMENDED SHEET
20. A method of isolating SAR mutants which possess a nucleic acid region which encodes a lipid transfer protein exhibiting SAR signal transducing property, wherein said protein acts upstream from the point of salicylic acid action along the signal transduction pathway: a. transforming plants with an insertional mutagen; b. observing for disease symptoms, c. isolating SAR mutants showing disease symptoms; d. spraying said SAR mutants with a salicylic acid like substance; e. observing the phenotypes of said SAR mutants; and f. selecting for said SAR mutants in which the wild type phenotype is Testored as a result of said spraying, wherein said SAR mutants in which said wild type phenotype is restored have a nucleic acid region encoding a lipid transfer protein exhibiting SAR signal transducing property, wherein said protein acts upstream from the point of salicylic acid action along the signal transduction pathway. AMENDE SHFFI —■ INTELLECTUAL PROPERTY OFFICE OF N.Z. 2 4 SEP 2001 RECEIVED 29
21. A nucleic acid molecule according to claim 1 substantially as herein described or exemplified.
22. A plant cell or plant according to claim 11 substantially as herein described or exemplified.
23. A recombinant nucleic acid molecule according to claim 13 substantially as herein described or exemplified.
24. A lipid transfer protein according to claim 14 or 15 substantially as herein described or exemplified.
25. An antibody according to claim 16 substantially as herein described or exemplified.
26. A method according to claim 17 substantially as herein described or exemplified.
27. A method according to claim 20 substantially as herein described or exemplified.
28. A nucleic acid molecule comprising a region encoding a lipid transfer protein capable of SAR signal transduction, wherein said region comprises nucleotides 36 to 341 as depicted in SEQ ID NO:l
29. A recombinant DNA molecule capable of functioning as a vector for plants comprising nucleotides 36 to 341 as depicted in SEQ ID NO:l.
30. A plant cell and plants transformed with a recombinant nucleic acid molecule substantially comprising nucleotides 36 to 341 as depicted in SEQ ID NO:l.
31. The plant cell and plants according to claim 30 wherein said recombinant nucleic acid molecule is integrated into the plants chromosomal DNA. INTELLECTUAL PROPERTY OFFICE OF N.Z. 2 4 SEP 2001 RECEIVED 30
32. A protein translated from said region encoding a lipid transfer protein of Claim 28.
33. A protein having an amino acid sequence as illustrated in SEQ ID NO:2.
34. A vector comprising the nucleic acid molecule of Claim 28.
35. A transformed plant comprising the vector of Claim 34.
36. A method of conferring Systemic Acquired Resistance (SAR) to a plant, comprising: transforming said plant with a vector comprising a nucleic acid encoding a lipid transfer protein which exhibits a SAR signal transducing property and is capable of directing SAR to a plant.
37. The method of Claim 36 wherein said nucleic acid region comprises nucleotides 36 to 341 as depicted in SEQ ID NO:l.
38. The method of Claim 36 wherein said protein has an amino acid sequence as illustrated in SEQ ID NO:2.
39. A method of isolating SAR mutants which comprise a region of DNA that encodes a protein which acts upstream from the point of salicylic acid action along a signal transduction pathway, comprising: a) transforming plants with an insertional mutagen; b) observing said plants for a disease phenotype; c) selecting for plants comprising mutations in the salicyclic acid signal transduction pathway; d) contacting said mutants with salicylic acid; and e) selecting for said mutants in which said disease phenotype is altered as a result of said contacting with salicylic acid. INTELLECTUAL PROPERTY OFFICE OF N.Z. 2 4 SEP 2001 RECEIVED ^ ffc 0, U P71 J w y o o / 31
40. An antibody capable of specifically binding the protein of claim 32 or 33.
41. Substantially pure cDNA comprising a nucleotide region as shown in SEQ ID NO:l.
42. Substantially pure cDNA encoding the amino acid sequence as shown in SEQ ID NO:2 or functional equivalents thereof, the cDNA being substantially free of cDNA that does not encode the amino acid sequence shown in SEQ ID NO:2 or functional equivalents thereof.
43. A nucleic acid molecule according to claim 28 substantially as herein described or exemplified.
44. A recombinant DNA molecule according to claim 29 substantially as herein described or exemplified.
45. A plant cell or plant according to claim 30 substantially as herein described or exemplified.
46. A protein according to claim 32 or 33 substantially as herein described or exemplified.
47. A vector according to claim 34 substantially as herein described or exemplified.
48. A method according to claim 36 substantially as herein described or exemplified.
49. A method according to claim 39 substantially as herein described or exemplified. INTELLECTUAL PROPERTY OFFICE OF N.Z. 2 4 SEP 2001 RECEIVED 32
50. An antibody according to claim 40 substantially as herein described or exemplified.
51. A substantially pure cDNA according to claim 41 or 42 substantially as herein described or exemplified. INTELLECTUAL PROPERTY OFFICE OF N.Z. 2 4 SEP 2001 RECEIVED
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4647597P | 1997-05-14 | 1997-05-14 | |
PCT/US1998/009863 WO1998051801A1 (en) | 1997-05-14 | 1998-05-14 | Gene encoding for systemic acquired resistance in arabidopsis |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ500887A true NZ500887A (en) | 2002-02-01 |
Family
ID=21943674
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ500887A NZ500887A (en) | 1997-05-14 | 1998-05-14 | Nucleic acid encoding lipid transfer protein which exhibits SAR (systemic acquired resistance) by specific process |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0981623A1 (en) |
JP (1) | JP2001525674A (en) |
AU (1) | AU7487598A (en) |
CA (1) | CA2289751A1 (en) |
IL (1) | IL132762A0 (en) |
NZ (1) | NZ500887A (en) |
WO (1) | WO1998051801A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001516588A (en) | 1997-09-15 | 2001-10-02 | インスティテュート・オブ・モレキュラー・アグロバイオロジー | RANK1, a rice-derived ankyrin repeat-containing peptide associated with disease resistance |
US9873889B2 (en) | 2013-08-02 | 2018-01-23 | Cornell University | Increasing leaf longevity and disease resistance by altering salicylic acid catabolism |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2083272A1 (en) * | 1991-05-24 | 1992-11-26 | Francisco Garcia-Olmedo | Novel antipathogenic peptides and compositions containing same |
GB9526238D0 (en) * | 1995-12-21 | 1996-02-21 | Sandoz Ltd | Improvements in or relating to organic compounds |
-
1998
- 1998-05-14 CA CA002289751A patent/CA2289751A1/en not_active Abandoned
- 1998-05-14 EP EP98922292A patent/EP0981623A1/en not_active Withdrawn
- 1998-05-14 IL IL13276298A patent/IL132762A0/en unknown
- 1998-05-14 AU AU74875/98A patent/AU7487598A/en not_active Abandoned
- 1998-05-14 WO PCT/US1998/009863 patent/WO1998051801A1/en not_active Application Discontinuation
- 1998-05-14 NZ NZ500887A patent/NZ500887A/en unknown
- 1998-05-14 JP JP54954498A patent/JP2001525674A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
AU7487598A (en) | 1998-12-08 |
JP2001525674A (en) | 2001-12-11 |
IL132762A0 (en) | 2001-03-19 |
WO1998051801A1 (en) | 1998-11-19 |
CA2289751A1 (en) | 1998-11-19 |
EP0981623A1 (en) | 2000-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU708035B2 (en) | Transgenic plants expressing dna constructs containing a plurality of genes to impart virus resistance | |
CA2112999C (en) | Pathogen-resistant transgenic plants | |
US5583021A (en) | Production of virus resistant plants | |
US6252138B1 (en) | Pathogen-induced plant promoters | |
EP0680514B1 (en) | Nematode-resistant transgenic plants | |
US8334427B2 (en) | Induction of Xa27 by the avrXa27 gene in rice confers broad-spectrum resistance to Xanthomonas oryzae pv. oryzae and enhanced resistance to Xanthomonas oryzae pv. oryzicola | |
US7138273B2 (en) | Method of identifying non-host plant disease resistance genes | |
CN111118053B (en) | Rice fertility regulation and control construct, transformation event and application thereof | |
AU2008249729A1 (en) | Method for increasing the resistance of a plant to endoparasitic nematodes | |
JP2003505076A (en) | Arabidopsis thaliana cyclic nucleotide gated ion channel / DND gene; regulator of plant disease resistance and cell death | |
AU707935B2 (en) | Transgenic plants exhibiting heterologous virus resistance | |
US20020059660A1 (en) | Transgenic plants expressing DNA constructs containing a plurality of genes to impart virus resistance | |
US5898097A (en) | Resistance to virus infection using modified viral movement protein | |
NZ500887A (en) | Nucleic acid encoding lipid transfer protein which exhibits SAR (systemic acquired resistance) by specific process | |
CN100383246C (en) | Rice zinc finger protein gene for negative regulating plant apoptosis and promoting growth and differentiation of transgene callus | |
MXPA99010515A (en) | Gene encoding for systemic acquired resistance in arabidopsis | |
US20040068764A1 (en) | Method of enhancing virus-resistance in plants and producing virus-immune plants | |
AU2004236279A1 (en) | Genetic sequences of plant pathogen avirulence genes and uses therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed |